BAMCO Inc
CDNA icon

BAMCO Inc’s CareDx CDNA Stock Holding History

BAMCO Inc’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.2M Sell
1,937,326
-1,399,083
-42% -$30.5M 0.08% 121
2026
Q1 		$57.9M Buy
3,336,409
+181,229
+6% +$3.43M 0.17% 95
2025
Q4 		$59.4M Hold
3,155,180
– – 0.16% 113
2025
Q3 		$45.9M Buy
3,155,180
+719,523
+30% +$10.3M 0.12% 146
2025
Q2 		$47.6M Buy
2,435,657
+245,651
+11% +$4.36M 0.13% 141
2025
Q1 		$38.9M Sell
2,190,006
-17,293
-0.8% -$372K 0.11% 146
2024
Q4 		$47.3M Buy
2,207,299
+330,627
+18% +$8.04M 0.12% 142
2024
Q3 		$58.6M Hold
1,876,672
– – 0.16% 120
2024
Q2 		$29.1M Buy
1,876,672
+646,772
+53% +$7.82M 0.08% 177
2024
Q1 		$13M Buy
+1,229,900
New +$12.3M 0.03% 228
2023
Q1 		– Sell
-2,058,339
Closed -$23.5M – 370
2022
Q4 		$23.5M Buy
2,058,339
+436,500
+27% +$6.47M 0.08% 167
2022
Q3 		$27.6M Buy
1,621,839
+582,868
+56% +$12.5M 0.09% 163
2022
Q2 		$22.3M Sell
1,038,971
-62,761
-6% -$1.74M 0.07% 196
2022
Q1 		$40.8M Buy
1,101,732
+1,024
+0.1% +$39.9K 0.1% 155
2021
Q4 		$50.1M Buy
1,100,708
+266,490
+32% +$13.9M 0.11% 166
2021
Q3 		$52.9M Buy
834,218
+106,989
+15% +$8.15M 0.12% 159
2021
Q2 		$66.6M Sell
727,229
-10,000
-1% -$795K 0.15% 130
2021
Q1 		$50.2M Hold
737,229
– – 0.12% 149
2020
Q4 		$53.4M Sell
737,229
-53,794
-7% -$3.12M 0.13% 136
2020
Q3 		$30M Buy
791,023
+15,000
+2% +$506K 0.09% 159
2020
Q2 		$27.5M Buy
776,023
+268,987
+53% +$7.65M 0.1% 149
2020
Q1 		$11.1M Buy
507,036
+90,000
+22% +$2.02M 0.05% 186
2019
Q4 		$8.99M Buy
417,036
+244,337
+141% +$5.61M 0.03% 222
2019
Q3 		$3.9M Sell
172,699
-337,066
-66% -$9.33M 0.02% 257
2019
Q2 		$18.3M Buy
509,765
+149,273
+41% +$4.78M 0.07% 178
2019
Q1 		$11.4M Sell
360,492
-43,000
-11% -$1.25M 0.05% 198
2018
Q4 		$10.1M Sell
403,492
-78,641
-16% -$2.02M 0.05% 195
2018
Q3 		$13.9M Buy
482,133
+77,133
+19% +$1.44M 0.06% 190
2018
Q2 		$4.96M Buy
+405,000
New +$4.64M 0.02% 237

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

BAMCO Inc's CDNA Position: Q2 2026 in Review

BAMCO Inc reduced its CareDx (CDNA) stake by 42% in Q2 2026, selling an estimated $30.5M and leaving 1,937,326 shares worth $55.2M. The position accounts for 0.08% of the portfolio, ranked #121.

BAMCO Inc first reported a position in CDNA in Q2 2018 and has held it in 29 quarters since. The position peaked at $66.6M in Q2 2021. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • BAMCO Inc held 1,937,326 shares of CareDx worth $55.2M as of Q2 2026.
  • BAMCO Inc sold 1,399,083 CareDx shares in Q2 2026, an estimated $30.5M.
  • CareDx made up 0.08% of BAMCO Inc's portfolio in Q2 2026, its #121 holding.
  • BAMCO Inc first reported a position in CareDx in Q2 2018 and has held it in 29 quarters since.
  • BAMCO Inc's CareDx position peaked at $66.6M in Q2 2021.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on BAMCO Inc's 13F filing for Q2 2026, filed 14 Aug 2026.